A Genotype-Guided Strategy for P2Y12 Inhibitors in PCI
Richard Gumina, MD, PhD, The Ohio State University College of Medicine, Columbus, OH
Richard Gumina, MD, PhD, The Ohio State University College of Medicine, Columbus, OH
Learning Objectives:
- Identify the role of a genotype guided strategy for P2Y12 inhibitors.
- Recognize the role of platelet function testing.
- Discuss if certain sub-populations benefit more (e.g, ACS vs. stable CAD) with a genotype guided strategy for P2Y12 inhibitors.
Keywords: Acute Coronary Syndromes (ACS), Coronary, Drug-eluting Stent (DES) and Pharmacotherapy